

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.31044498 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.56016573 |
| 3 | vocalization behavior (GO:0071625) | 5.48085509 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.45130615 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.43221841 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.43000007 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.37279170 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.30950411 |
| 9 | glutamate secretion (GO:0014047) | 5.22688642 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.03820153 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.91040291 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.89475226 |
| 13 | protein localization to synapse (GO:0035418) | 4.82831113 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.65570488 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.59303465 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.50481727 |
| 17 | exploration behavior (GO:0035640) | 4.48536538 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.46768751 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.43852270 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.40955798 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 4.37982355 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.35749835 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.34976251 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.33348333 |
| 25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.17956084 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 4.11071824 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 4.05577201 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 3.99384827 |
| 29 | synaptic vesicle endocytosis (GO:0048488) | 3.94574394 |
| 30 | long-term memory (GO:0007616) | 3.85879209 |
| 31 | dendritic spine morphogenesis (GO:0060997) | 3.85632513 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 3.83629991 |
| 33 | positive regulation of synapse maturation (GO:0090129) | 3.82501647 |
| 34 | chemosensory behavior (GO:0007635) | 3.81363892 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.79132256 |
| 36 | neurotransmitter transport (GO:0006836) | 3.75658211 |
| 37 | detection of calcium ion (GO:0005513) | 3.75465875 |
| 38 | neuron recognition (GO:0008038) | 3.73608795 |
| 39 | neuromuscular process controlling posture (GO:0050884) | 3.67965461 |
| 40 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.67114144 |
| 41 | cellular potassium ion homeostasis (GO:0030007) | 3.65419622 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.64857745 |
| 43 | proline transport (GO:0015824) | 3.63840722 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.61898549 |
| 45 | positive regulation of membrane potential (GO:0045838) | 3.61444239 |
| 46 | cerebellar Purkinje cell layer development (GO:0021680) | 3.60140644 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.54348698 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.54330004 |
| 49 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.54153256 |
| 50 | long-term synaptic potentiation (GO:0060291) | 3.54090106 |
| 51 | transmission of nerve impulse (GO:0019226) | 3.52533646 |
| 52 | positive regulation of neurotransmitter transport (GO:0051590) | 3.51446756 |
| 53 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.49984045 |
| 54 | regulation of neurotransmitter levels (GO:0001505) | 3.49726193 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.48217487 |
| 56 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.46020868 |
| 57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.42135884 |
| 58 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.41107253 |
| 59 | potassium ion homeostasis (GO:0055075) | 3.40991313 |
| 60 | behavioral defense response (GO:0002209) | 3.38378047 |
| 61 | behavioral fear response (GO:0001662) | 3.38378047 |
| 62 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.37563445 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.32573168 |
| 64 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.28803659 |
| 65 | axonal fasciculation (GO:0007413) | 3.28416231 |
| 66 | activation of protein kinase A activity (GO:0034199) | 3.28052305 |
| 67 | dendritic spine organization (GO:0097061) | 3.27653233 |
| 68 | sodium ion export (GO:0071436) | 3.27514415 |
| 69 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.27168927 |
| 70 | neuromuscular process controlling balance (GO:0050885) | 3.26361417 |
| 71 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.25081493 |
| 72 | righting reflex (GO:0060013) | 3.22146874 |
| 73 | regulation of vesicle fusion (GO:0031338) | 3.16789882 |
| 74 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.16359682 |
| 75 | fear response (GO:0042596) | 3.15016791 |
| 76 | membrane hyperpolarization (GO:0060081) | 3.13683372 |
| 77 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.13257583 |
| 78 | dendrite morphogenesis (GO:0048813) | 3.11197827 |
| 79 | membrane depolarization (GO:0051899) | 3.11099296 |
| 80 | mating behavior (GO:0007617) | 3.10222562 |
| 81 | innervation (GO:0060384) | 3.10056322 |
| 82 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.09522758 |
| 83 | regulation of glutamate secretion (GO:0014048) | 3.09401821 |
| 84 | postsynaptic membrane organization (GO:0001941) | 3.07875813 |
| 85 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07338328 |
| 86 | learning (GO:0007612) | 3.06293156 |
| 87 | presynaptic membrane organization (GO:0097090) | 3.05492040 |
| 88 | cell communication by electrical coupling (GO:0010644) | 3.04920671 |
| 89 | regulation of neurotransmitter transport (GO:0051588) | 3.04382541 |
| 90 | membrane depolarization during action potential (GO:0086010) | 3.02770726 |
| 91 | positive regulation of synaptic transmission (GO:0050806) | 3.02433384 |
| 92 | regulation of synaptic transmission (GO:0050804) | 3.02406322 |
| 93 | synaptic transmission (GO:0007268) | 3.01922815 |
| 94 | prepulse inhibition (GO:0060134) | 3.01095156 |
| 95 | cellular sodium ion homeostasis (GO:0006883) | 3.00961417 |
| 96 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.00869029 |
| 97 | cell communication involved in cardiac conduction (GO:0086065) | 3.00622329 |
| 98 | regulation of synapse maturation (GO:0090128) | 2.99600352 |
| 99 | behavioral response to cocaine (GO:0048148) | 2.99583678 |
| 100 | synapse assembly (GO:0007416) | 2.99464583 |
| 101 | positive regulation of dendritic spine development (GO:0060999) | 2.98807288 |
| 102 | neuromuscular process (GO:0050905) | 2.96051398 |
| 103 | response to histamine (GO:0034776) | 2.95793073 |
| 104 | cerebellar granule cell differentiation (GO:0021707) | 2.95282733 |
| 105 | regulation of ARF protein signal transduction (GO:0032012) | 2.94852603 |
| 106 | presynaptic membrane assembly (GO:0097105) | 2.94381581 |
| 107 | neuronal ion channel clustering (GO:0045161) | 2.94302362 |
| 108 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.94223227 |
| 109 | neurofilament cytoskeleton organization (GO:0060052) | 2.93955017 |
| 110 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.93729617 |
| 111 | social behavior (GO:0035176) | 2.92541153 |
| 112 | intraspecies interaction between organisms (GO:0051703) | 2.92541153 |
| 113 | response to auditory stimulus (GO:0010996) | 2.89711782 |
| 114 | signal release (GO:0023061) | 2.87887913 |
| 115 | startle response (GO:0001964) | 2.86935749 |
| 116 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.86110582 |
| 117 | regulation of dendritic spine development (GO:0060998) | 2.85663295 |
| 118 | auditory behavior (GO:0031223) | 2.84992910 |
| 119 | urinary tract smooth muscle contraction (GO:0014848) | 2.84298696 |
| 120 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.75951709 |
| 121 | negative regulation of dendrite development (GO:2000171) | 2.75160133 |
| 122 | serotonin metabolic process (GO:0042428) | 2.73930899 |
| 123 | long term synaptic depression (GO:0060292) | 2.72392370 |
| 124 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.71391056 |
| 125 | calcium ion-dependent exocytosis (GO:0017156) | 2.69317592 |
| 126 | establishment of synaptic vesicle localization (GO:0097480) | 2.68366376 |
| 127 | synaptic vesicle transport (GO:0048489) | 2.68366376 |
| 128 | insulin secretion (GO:0030073) | 2.61395236 |
| 129 | potassium ion import (GO:0010107) | 2.58443758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.16336181 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.54018500 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13449170 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10450772 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07209411 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.78006156 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71520734 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71520734 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.71470875 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63533713 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57033298 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53794102 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51336948 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49409584 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45578571 |
| 16 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.45056550 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34936842 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.32209829 |
| 19 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.29568161 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28080766 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26729508 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.22601508 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.18267412 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.17350095 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13029966 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.11582988 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.99261215 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96007527 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92933950 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88261835 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85363613 |
| 32 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81930889 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78596770 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76771618 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59282220 |
| 36 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59036446 |
| 37 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57657062 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48204531 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47310133 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.46737127 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42565903 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41777321 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39917017 |
| 44 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33794454 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32664790 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30731749 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30695321 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29359620 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28010107 |
| 50 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27828466 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26606026 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26213510 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24781544 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23612985 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20638480 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20482038 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19038913 |
| 58 | AR_19668381_ChIP-Seq_PC3_Human | 1.18878922 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17585731 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17143709 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15070684 |
| 62 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14333409 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14048664 |
| 64 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.13596990 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12730018 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12562059 |
| 67 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12349402 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11507027 |
| 69 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.11307774 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11190121 |
| 71 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09777343 |
| 72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08705790 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06501512 |
| 74 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05532875 |
| 75 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02746678 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02524664 |
| 77 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02465210 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02049088 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99479853 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98191389 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97977652 |
| 82 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97710338 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97499739 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97299685 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96081166 |
| 86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94879791 |
| 87 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94669820 |
| 88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94515961 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94167882 |
| 90 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93966952 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92866795 |
| 92 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92520950 |
| 93 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92373312 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91882034 |
| 95 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91184633 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90893418 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90893418 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90553113 |
| 99 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90129900 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89793875 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89403301 |
| 102 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89103856 |
| 103 | FUS_26573619_Chip-Seq_HEK293_Human | 0.88504482 |
| 104 | JUN_21703547_ChIP-Seq_K562_Human | 0.87857048 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86834362 |
| 106 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86440999 |
| 107 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85566144 |
| 108 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84914261 |
| 109 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84652583 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84109561 |
| 111 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83175119 |
| 112 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82844865 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.81158422 |
| 114 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80764971 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79754404 |
| 116 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.79579225 |
| 117 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77064755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.34153034 |
| 2 | MP0003880_abnormal_central_pattern | 4.95250618 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.16912453 |
| 4 | MP0009745_abnormal_behavioral_response | 3.48337773 |
| 5 | MP0004270_analgesia | 3.37755927 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.37245782 |
| 7 | MP0002064_seizures | 3.25250280 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.17135657 |
| 9 | MP0009046_muscle_twitch | 3.07798109 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.85093933 |
| 11 | MP0002272_abnormal_nervous_system | 2.66965779 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.62317461 |
| 13 | MP0002822_catalepsy | 2.61424114 |
| 14 | MP0002736_abnormal_nociception_after | 2.53288820 |
| 15 | MP0001486_abnormal_startle_reflex | 2.52542043 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.50000241 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.41346502 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.37184692 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.32853514 |
| 20 | MP0006276_abnormal_autonomic_nervous | 2.12232565 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.02996043 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.01505510 |
| 23 | MP0003329_amyloid_beta_deposits | 2.00362408 |
| 24 | MP0002184_abnormal_innervation | 1.92436122 |
| 25 | MP0001970_abnormal_pain_threshold | 1.90289669 |
| 26 | MP0002557_abnormal_social/conspecific_i | 1.78710138 |
| 27 | MP0000778_abnormal_nervous_system | 1.78404346 |
| 28 | MP0004858_abnormal_nervous_system | 1.76137564 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.72050632 |
| 30 | MP0004924_abnormal_behavior | 1.72050632 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.72009061 |
| 32 | MP0001984_abnormal_olfaction | 1.69180472 |
| 33 | MP0008569_lethality_at_weaning | 1.67693837 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.67163590 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.66288062 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.57241203 |
| 37 | MP0003879_abnormal_hair_cell | 1.56548409 |
| 38 | MP0000955_abnormal_spinal_cord | 1.54064002 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.53988908 |
| 40 | MP0003122_maternal_imprinting | 1.52674257 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.51669497 |
| 42 | MP0001529_abnormal_vocalization | 1.46613744 |
| 43 | MP0004142_abnormal_muscle_tone | 1.45703900 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.42659539 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.41733934 |
| 46 | MP0003195_calcinosis | 1.38504805 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.36107003 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.34041095 |
| 49 | MP0004885_abnormal_endolymph | 1.33361889 |
| 50 | MP0003787_abnormal_imprinting | 1.24463490 |
| 51 | MP0001905_abnormal_dopamine_level | 1.24432520 |
| 52 | MP0003633_abnormal_nervous_system | 1.20763127 |
| 53 | MP0004043_abnormal_pH_regulation | 1.17246061 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.12256492 |
| 55 | MP0002152_abnormal_brain_morphology | 1.07163239 |
| 56 | MP0003631_nervous_system_phenotype | 1.06323592 |
| 57 | MP0001944_abnormal_pancreas_morphology | 1.05182759 |
| 58 | MP0002229_neurodegeneration | 1.03187457 |
| 59 | MP0008872_abnormal_physiological_respon | 1.03108869 |
| 60 | MP0002069_abnormal_eating/drinking_beha | 1.01672526 |
| 61 | MP0008874_decreased_physiological_sensi | 0.94929409 |
| 62 | MP0000604_amyloidosis | 0.94319606 |
| 63 | MP0004742_abnormal_vestibular_system | 0.92367120 |
| 64 | MP0010386_abnormal_urinary_bladder | 0.91776491 |
| 65 | MP0005535_abnormal_body_temperature | 0.91000868 |
| 66 | MP0002876_abnormal_thyroid_physiology | 0.90686594 |
| 67 | MP0001188_hyperpigmentation | 0.89807075 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 0.89114593 |
| 69 | MP0001177_atelectasis | 0.88570435 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 0.88449905 |
| 71 | MP0002693_abnormal_pancreas_physiology | 0.87642419 |
| 72 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86364220 |
| 73 | MP0000751_myopathy | 0.85984755 |
| 74 | MP0001963_abnormal_hearing_physiology | 0.84966290 |
| 75 | MP0002752_abnormal_somatic_nervous | 0.83297029 |
| 76 | MP0002090_abnormal_vision | 0.82860032 |
| 77 | MP0003632_abnormal_nervous_system | 0.82273700 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.81741114 |
| 79 | MP0004085_abnormal_heartbeat | 0.80239524 |
| 80 | MP0005394_taste/olfaction_phenotype | 0.79615105 |
| 81 | MP0005499_abnormal_olfactory_system | 0.79615105 |
| 82 | MP0003690_abnormal_glial_cell | 0.79352476 |
| 83 | MP0003634_abnormal_glial_cell | 0.78636879 |
| 84 | MP0002653_abnormal_ependyma_morphology | 0.78317326 |
| 85 | MP0004510_myositis | 0.77580561 |
| 86 | MP0003011_delayed_dark_adaptation | 0.77458620 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 0.75770370 |
| 88 | MP0005379_endocrine/exocrine_gland_phen | 0.75357669 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.75074593 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.75042996 |
| 91 | MP0000566_synostosis | 0.74851562 |
| 92 | MP0000427_abnormal_hair_cycle | 0.72948330 |
| 93 | MP0002102_abnormal_ear_morphology | 0.68434141 |
| 94 | MP0003075_altered_response_to | 0.67840053 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.67296990 |
| 96 | MP0000920_abnormal_myelination | 0.67113514 |
| 97 | MP0003953_abnormal_hormone_level | 0.66887292 |
| 98 | MP0000013_abnormal_adipose_tissue | 0.66845881 |
| 99 | MP0005448_abnormal_energy_balance | 0.64400228 |
| 100 | MP0001756_abnormal_urination | 0.63686244 |
| 101 | MP0001485_abnormal_pinna_reflex | 0.62394149 |
| 102 | MP0003123_paternal_imprinting | 0.60880487 |
| 103 | MP0000639_abnormal_adrenal_gland | 0.60332402 |
| 104 | MP0010329_abnormal_lipoprotein_level | 0.59594347 |
| 105 | MP0005253_abnormal_eye_physiology | 0.59469990 |
| 106 | MP0005085_abnormal_gallbladder_physiolo | 0.59406940 |
| 107 | MP0002928_abnormal_bile_duct | 0.58395767 |
| 108 | MP0003868_abnormal_feces_composition | 0.57899367 |
| 109 | MP0003137_abnormal_impulse_conducting | 0.57779370 |
| 110 | MP0010678_abnormal_skin_adnexa | 0.56984759 |
| 111 | MP0001664_abnormal_digestion | 0.56626975 |
| 112 | MP0002638_abnormal_pupillary_reflex | 0.55644495 |
| 113 | MP0003861_abnormal_nervous_system | 0.53111558 |
| 114 | MP0003283_abnormal_digestive_organ | 0.52681357 |
| 115 | MP0002082_postnatal_lethality | 0.52586859 |
| 116 | MP0010770_preweaning_lethality | 0.52586859 |
| 117 | MP0010769_abnormal_survival | 0.52567613 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.52499089 |
| 119 | MP0001943_abnormal_respiration | 0.52219867 |
| 120 | MP0003956_abnormal_body_size | 0.51650983 |
| 121 | MP0004233_abnormal_muscle_weight | 0.51586240 |
| 122 | MP0006072_abnormal_retinal_apoptosis | 0.49958581 |
| 123 | MP0010768_mortality/aging | 0.49312624 |
| 124 | MP0000026_abnormal_inner_ear | 0.49179505 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.48301294 |
| 126 | MP0003121_genomic_imprinting | 0.48005155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.30715619 |
| 2 | Myokymia (HP:0002411) | 7.02844177 |
| 3 | Focal seizures (HP:0007359) | 5.94599705 |
| 4 | Visual hallucinations (HP:0002367) | 5.79868564 |
| 5 | Atonic seizures (HP:0010819) | 4.84721180 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.77626740 |
| 7 | Absence seizures (HP:0002121) | 4.71583995 |
| 8 | Febrile seizures (HP:0002373) | 4.70403110 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.30856550 |
| 10 | Dialeptic seizures (HP:0011146) | 4.22890753 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.07112752 |
| 12 | Hypoglycemic seizures (HP:0002173) | 3.75026485 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.72753324 |
| 14 | Action tremor (HP:0002345) | 3.71884633 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.50342001 |
| 16 | Hyperventilation (HP:0002883) | 3.47713132 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.40056188 |
| 18 | Poor eye contact (HP:0000817) | 3.33719483 |
| 19 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.29537831 |
| 20 | Broad-based gait (HP:0002136) | 3.27850708 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.25136136 |
| 22 | Abnormality of the lower motor neuron (HP:0002366) | 3.17865783 |
| 23 | Increased circulating renin level (HP:0000848) | 3.14480206 |
| 24 | Impaired social interactions (HP:0000735) | 3.13920833 |
| 25 | Abnormal social behavior (HP:0012433) | 3.13920833 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.10221935 |
| 27 | Abnormal eating behavior (HP:0100738) | 3.09097975 |
| 28 | Depression (HP:0000716) | 3.07180055 |
| 29 | Ankle clonus (HP:0011448) | 3.06265985 |
| 30 | Dysmetria (HP:0001310) | 3.02713103 |
| 31 | Postural instability (HP:0002172) | 2.96069502 |
| 32 | Anxiety (HP:0000739) | 2.95974770 |
| 33 | Amblyopia (HP:0000646) | 2.95453686 |
| 34 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.89736704 |
| 35 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83389773 |
| 36 | Status epilepticus (HP:0002133) | 2.82689923 |
| 37 | Excessive salivation (HP:0003781) | 2.80194539 |
| 38 | Drooling (HP:0002307) | 2.80194539 |
| 39 | Truncal ataxia (HP:0002078) | 2.75210972 |
| 40 | Mutism (HP:0002300) | 2.71861836 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.67193705 |
| 42 | Ketoacidosis (HP:0001993) | 2.66883001 |
| 43 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.65996141 |
| 44 | Spastic gait (HP:0002064) | 2.63848445 |
| 45 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.61941329 |
| 46 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.61941329 |
| 47 | Torticollis (HP:0000473) | 2.60965455 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.60853958 |
| 49 | Epileptiform EEG discharges (HP:0011182) | 2.58190107 |
| 50 | Scanning speech (HP:0002168) | 2.58034680 |
| 51 | Progressive inability to walk (HP:0002505) | 2.55128932 |
| 52 | Polyphagia (HP:0002591) | 2.50913009 |
| 53 | Focal dystonia (HP:0004373) | 2.50223908 |
| 54 | Genetic anticipation (HP:0003743) | 2.49672991 |
| 55 | Sleep apnea (HP:0010535) | 2.49615148 |
| 56 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49270991 |
| 57 | Hemiparesis (HP:0001269) | 2.48223994 |
| 58 | Akinesia (HP:0002304) | 2.47756299 |
| 59 | Urinary urgency (HP:0000012) | 2.46964473 |
| 60 | Intention tremor (HP:0002080) | 2.45361653 |
| 61 | Hyperglycemia (HP:0003074) | 2.44045560 |
| 62 | Hypothermia (HP:0002045) | 2.41975745 |
| 63 | Impaired smooth pursuit (HP:0007772) | 2.41513308 |
| 64 | Bradykinesia (HP:0002067) | 2.41054346 |
| 65 | Absent speech (HP:0001344) | 2.38531428 |
| 66 | Generalized myoclonic seizures (HP:0002123) | 2.37931917 |
| 67 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.37600367 |
| 68 | Hemiplegia (HP:0002301) | 2.35805630 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.33005898 |
| 70 | Impaired vibratory sensation (HP:0002495) | 2.27958193 |
| 71 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.26839567 |
| 72 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.26839567 |
| 73 | Craniofacial dystonia (HP:0012179) | 2.26254705 |
| 74 | Gait imbalance (HP:0002141) | 2.24269796 |
| 75 | Abnormality of the corticospinal tract (HP:0002492) | 2.19160039 |
| 76 | Large for gestational age (HP:0001520) | 2.16638155 |
| 77 | Blue irides (HP:0000635) | 2.16504643 |
| 78 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.16224561 |
| 79 | Papilledema (HP:0001085) | 2.14603489 |
| 80 | Delusions (HP:0000746) | 2.13785489 |
| 81 | Rhinitis (HP:0012384) | 2.13481507 |
| 82 | Inability to walk (HP:0002540) | 2.12933707 |
| 83 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.11978879 |
| 84 | Diplopia (HP:0000651) | 2.11325356 |
| 85 | Abnormality of binocular vision (HP:0011514) | 2.11325356 |
| 86 | Ventricular fibrillation (HP:0001663) | 2.10614254 |
| 87 | Symptomatic seizures (HP:0011145) | 2.10032616 |
| 88 | Stereotypic behavior (HP:0000733) | 2.09754474 |
| 89 | Abnormal ciliary motility (HP:0012262) | 2.08752092 |
| 90 | Diminished movement (HP:0002374) | 2.08310280 |
| 91 | Termporal pattern (HP:0011008) | 2.06986829 |
| 92 | Insidious onset (HP:0003587) | 2.06986829 |
| 93 | Muscular hypotonia of the trunk (HP:0008936) | 2.06780770 |
| 94 | Late onset (HP:0003584) | 2.06432461 |
| 95 | Lower limb muscle weakness (HP:0007340) | 2.05479950 |
| 96 | Psychosis (HP:0000709) | 2.05133301 |
| 97 | Postural tremor (HP:0002174) | 2.04849496 |
| 98 | Pheochromocytoma (HP:0002666) | 2.01124901 |
| 99 | Gait ataxia (HP:0002066) | 2.01115786 |
| 100 | Fetal akinesia sequence (HP:0001989) | 2.01026508 |
| 101 | Failure to thrive in infancy (HP:0001531) | 2.00405437 |
| 102 | Agitation (HP:0000713) | 1.99985933 |
| 103 | Peripheral hypomyelination (HP:0007182) | 1.98294303 |
| 104 | Dysmetric saccades (HP:0000641) | 1.96043947 |
| 105 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.91964058 |
| 106 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.91964058 |
| 107 | Obstructive sleep apnea (HP:0002870) | 1.91841751 |
| 108 | Abnormality of saccadic eye movements (HP:0000570) | 1.90997558 |
| 109 | Hyperphosphatemia (HP:0002905) | 1.89526571 |
| 110 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.89335510 |
| 111 | Hypomagnesemia (HP:0002917) | 1.88764428 |
| 112 | Cerebral hypomyelination (HP:0006808) | 1.88312067 |
| 113 | Limb dystonia (HP:0002451) | 1.87992183 |
| 114 | Hypoventilation (HP:0002791) | 1.87688182 |
| 115 | Medial flaring of the eyebrow (HP:0010747) | 1.87657106 |
| 116 | Hypokinesia (HP:0002375) | 1.87513214 |
| 117 | Incomplete penetrance (HP:0003829) | 1.87484755 |
| 118 | Poor suck (HP:0002033) | 1.86965093 |
| 119 | Megalencephaly (HP:0001355) | 1.84688174 |
| 120 | Annular pancreas (HP:0001734) | 1.84408354 |
| 121 | Neuronal loss in central nervous system (HP:0002529) | 1.83588216 |
| 122 | Congenital malformation of the right heart (HP:0011723) | 1.83189679 |
| 123 | Double outlet right ventricle (HP:0001719) | 1.83189679 |
| 124 | Specific learning disability (HP:0001328) | 1.82970228 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 1.82587341 |
| 126 | Syncope (HP:0001279) | 1.82265863 |
| 127 | Clonus (HP:0002169) | 1.81626341 |
| 128 | Enlarged penis (HP:0000040) | 1.81084960 |
| 129 | Abnormality of salivation (HP:0100755) | 1.79776897 |
| 130 | Retinal dysplasia (HP:0007973) | 1.79465397 |
| 131 | Insomnia (HP:0100785) | 1.79423438 |
| 132 | Rapidly progressive (HP:0003678) | 1.77965196 |
| 133 | Type II lissencephaly (HP:0007260) | 1.76386290 |
| 134 | Hypoplasia of the brainstem (HP:0002365) | 1.74960783 |
| 135 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.74960783 |
| 136 | Rigidity (HP:0002063) | 1.74832614 |
| 137 | Amyotrophic lateral sclerosis (HP:0007354) | 1.73913215 |
| 138 | Neuroendocrine neoplasm (HP:0100634) | 1.73392621 |
| 139 | Spastic tetraplegia (HP:0002510) | 1.72446252 |
| 140 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.72332942 |
| 141 | Esotropia (HP:0000565) | 1.72086540 |
| 142 | Anosmia (HP:0000458) | 1.71863993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.67106589 |
| 2 | EPHA4 | 4.18132406 |
| 3 | MAP3K9 | 4.02438511 |
| 4 | MAP3K4 | 2.98819429 |
| 5 | MINK1 | 2.84668884 |
| 6 | MARK1 | 2.72716646 |
| 7 | MAP2K7 | 2.45722634 |
| 8 | DAPK2 | 2.44258708 |
| 9 | MAP3K12 | 2.37527420 |
| 10 | FRK | 2.36906289 |
| 11 | KSR2 | 2.23500983 |
| 12 | PAK6 | 2.23084442 |
| 13 | MAP2K4 | 2.20739313 |
| 14 | NTRK2 | 2.16383002 |
| 15 | CASK | 1.99543122 |
| 16 | KSR1 | 1.87916976 |
| 17 | MAP4K2 | 1.84608895 |
| 18 | TESK1 | 1.82160910 |
| 19 | ARAF | 1.75753153 |
| 20 | FGFR2 | 1.72975482 |
| 21 | PRKD3 | 1.69016954 |
| 22 | TNIK | 1.62982232 |
| 23 | NTRK1 | 1.62580913 |
| 24 | DAPK1 | 1.58932658 |
| 25 | RIPK4 | 1.56595301 |
| 26 | FES | 1.52849855 |
| 27 | PNCK | 1.50831063 |
| 28 | GRK5 | 1.48586624 |
| 29 | CDK5 | 1.47954534 |
| 30 | CAMKK1 | 1.47805926 |
| 31 | TYRO3 | 1.45827853 |
| 32 | PRPF4B | 1.41264290 |
| 33 | PLK2 | 1.38754422 |
| 34 | MAP3K13 | 1.36978145 |
| 35 | SIK2 | 1.34068179 |
| 36 | MAPK13 | 1.29876546 |
| 37 | PRKCG | 1.29786284 |
| 38 | UHMK1 | 1.27720457 |
| 39 | STK38 | 1.27647866 |
| 40 | CDK19 | 1.14698606 |
| 41 | LATS2 | 1.08184153 |
| 42 | MAP3K2 | 1.06080157 |
| 43 | CAMK2A | 1.04019837 |
| 44 | SIK3 | 0.99404469 |
| 45 | CSNK1G3 | 0.98609216 |
| 46 | PHKG1 | 0.97629141 |
| 47 | PHKG2 | 0.97629141 |
| 48 | CDK18 | 0.91340848 |
| 49 | MAPK15 | 0.88767431 |
| 50 | SGK223 | 0.87416487 |
| 51 | SGK494 | 0.87416487 |
| 52 | CAMK1 | 0.86710907 |
| 53 | CDK14 | 0.86587150 |
| 54 | CDK15 | 0.86052953 |
| 55 | TAOK1 | 0.85976592 |
| 56 | LIMK1 | 0.85938260 |
| 57 | CSNK1G1 | 0.84812445 |
| 58 | CAMK2B | 0.83786453 |
| 59 | MAP2K6 | 0.82433298 |
| 60 | RAF1 | 0.82108865 |
| 61 | PAK3 | 0.81956739 |
| 62 | PTK2B | 0.80046193 |
| 63 | DYRK1A | 0.78649335 |
| 64 | PINK1 | 0.78331126 |
| 65 | RET | 0.77080824 |
| 66 | STK11 | 0.74697054 |
| 67 | CDK11A | 0.74188162 |
| 68 | ERBB3 | 0.72601783 |
| 69 | CAMKK2 | 0.72037585 |
| 70 | PRKAA1 | 0.71463011 |
| 71 | CSNK1A1L | 0.70916273 |
| 72 | LMTK2 | 0.70290622 |
| 73 | FER | 0.69863483 |
| 74 | PRKCH | 0.68887864 |
| 75 | SGK2 | 0.67563310 |
| 76 | TNK2 | 0.67101518 |
| 77 | OXSR1 | 0.66936696 |
| 78 | NME1 | 0.64508879 |
| 79 | MAP3K1 | 0.63652419 |
| 80 | BMPR2 | 0.60617394 |
| 81 | HIPK2 | 0.60413427 |
| 82 | SGK1 | 0.59602243 |
| 83 | PRKCZ | 0.58349684 |
| 84 | FGR | 0.57504547 |
| 85 | MARK2 | 0.57424345 |
| 86 | CAMK2G | 0.56914724 |
| 87 | BRAF | 0.54966702 |
| 88 | CSNK1G2 | 0.54898102 |
| 89 | CAMK2D | 0.54888592 |
| 90 | BCR | 0.54481833 |
| 91 | AKT3 | 0.53220717 |
| 92 | DMPK | 0.52903312 |
| 93 | INSRR | 0.52283176 |
| 94 | CSNK1D | 0.52000035 |
| 95 | PRKCE | 0.51337881 |
| 96 | SGK3 | 0.51192066 |
| 97 | MAP3K6 | 0.50714850 |
| 98 | MAP2K1 | 0.49439914 |
| 99 | RPS6KA3 | 0.48051006 |
| 100 | FGFR3 | 0.48030008 |
| 101 | PDPK1 | 0.47163423 |
| 102 | PDK1 | 0.47068156 |
| 103 | TRIM28 | 0.46377876 |
| 104 | CAMK1G | 0.44763394 |
| 105 | CSNK1A1 | 0.44028430 |
| 106 | MAPK12 | 0.43538058 |
| 107 | MAPK10 | 0.42367254 |
| 108 | ALK | 0.42339194 |
| 109 | MAP3K7 | 0.41504963 |
| 110 | CAMK4 | 0.41164534 |
| 111 | PRKCI | 0.38769852 |
| 112 | FYN | 0.38577545 |
| 113 | NEK1 | 0.38407927 |
| 114 | PRKG1 | 0.37740338 |
| 115 | CAMK1D | 0.36417559 |
| 116 | PKN1 | 0.36342062 |
| 117 | DYRK2 | 0.36180776 |
| 118 | SCYL2 | 0.35888325 |
| 119 | CDC42BPA | 0.35552710 |
| 120 | PRKCB | 0.32211461 |
| 121 | WNK3 | 0.31973244 |
| 122 | PRKACA | 0.31502723 |
| 123 | PRKCA | 0.30846402 |
| 124 | NEK6 | 0.29834865 |
| 125 | RPS6KA2 | 0.29079281 |
| 126 | CSNK1E | 0.28623000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.06500568 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.48572839 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.86021852 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.76574546 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75583932 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.65714084 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.59738607 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58068776 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.53509177 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.47882368 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.30647508 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14427873 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05124785 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.03999184 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.93307575 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.86607307 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80490129 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71495663 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68733866 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.64952124 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64835034 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62035139 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50516133 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50425329 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.50025876 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49434741 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49046203 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48811298 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.48767948 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43661994 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41881315 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35245669 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30546092 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27566246 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24789517 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.22823813 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19824595 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14198160 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10905185 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.05995901 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05477259 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03724740 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02414936 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01258403 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98704073 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97318382 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96245303 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94580160 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.93878257 |
| 50 | Glioma_Homo sapiens_hsa05214 | 0.93274063 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92730953 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 0.89255899 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86529197 |
| 54 | Protein export_Homo sapiens_hsa03060 | 0.83435947 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82939542 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.80688930 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78988633 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77570817 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.76934447 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75956746 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73891227 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73125472 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72599090 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71390435 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71105096 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70711495 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70024184 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69241294 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67933062 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67606785 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64704443 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62755038 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59536510 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58871415 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56802633 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54582549 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53320491 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52361328 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51856250 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51673868 |
| 81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50886706 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50838093 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49578797 |
| 84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48761440 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47606014 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46991714 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45998402 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44454356 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.44096985 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42038363 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41611854 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.40821715 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40479707 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37902297 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37015563 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36924220 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35910754 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34206079 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34088823 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32688300 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.32595218 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.31977311 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31047215 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30467190 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30367655 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30356302 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30156601 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29710588 |
| 109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29704674 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27915672 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27605759 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27290165 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26913755 |
| 114 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.26564629 |
| 115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.25738112 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.25575326 |
| 117 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.24951040 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.24614343 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24454368 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24142640 |

